東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Gastrointestinal system- Microbiology." ]

切換: 標籤 | MARC模式 | ISBD

Probiotics and child gastrointestina...

Guandalini, Stefano.

FindBook

Google Book

Amazon

博客來

Probiotics and child gastrointestinal health = advances in microbiology, infectious diseases and public health.. Volume 10 /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Probiotics and child gastrointestinal health/ edited by Stefano Guandalini, Flavia Indrio.
其他題名:	advances in microbiology, infectious diseases and public health.
其他作者:	Guandalini, Stefano.
出版者:	Cham :Springer International Publishing : : 2019.,
面頁冊數:	viii, 150 p. :ill., digital ;24 cm.
內容註:	From the contents: 1. The newborn -- Microbiota development of newborns starts in utero -- Pathogenesis and possible prevention of Necrotizing Enterocolitis -- Can post-biotics represent a new strategy for NEC? - 2. The Infant -- Preventing and treating colics -- Food Allergy prevention -- Can celiac disease be prevented with probiotics? 3. The child -- Fighting fatty liver with probiotics -- Inflammatory Bowel Disease -- Acute Infectious Diarrhea -- Functional GI disorders -- Clostridium difficile colitis prevention and treatment.
Contained By:	Springer eBooks
標題:	Pediatric gastroenterology. -
電子資源:	https://doi.org/10.1007/978-3-030-14636-8
ISBN:	9783030146368

Probiotics and child gastrointestinal health = advances in microbiology, infectious diseases and public health.. Volume 10 /
Probiotics and child gastrointestinal healthadvances in microbiology, infectious diseases and public health.Volume 10 /[electronic resource] :edited by Stefano Guandalini, Flavia Indrio. - Cham :Springer International Publishing :2019. - viii, 150 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology ;v.1125. - Advances in experimental medicine and biology ;v.1125..

From the contents: 1. The newborn -- Microbiota development of newborns starts in utero -- Pathogenesis and possible prevention of Necrotizing Enterocolitis -- Can post-biotics represent a new strategy for NEC? - 2. The Infant -- Preventing and treating colics -- Food Allergy prevention -- Can celiac disease be prevented with probiotics? 3. The child -- Fighting fatty liver with probiotics -- Inflammatory Bowel Disease -- Acute Infectious Diarrhea -- Functional GI disorders -- Clostridium difficile colitis prevention and treatment.

This book shows the huge impact the gut microbiota has on the gastrointestinal health of humans with a particular focus on children. It also highlights the potential use of probiotic microorganisms to protect or improve children's gastrointestinal health. Humans are not single organisms: We are a multi-organism structure composed of ourselves and our microbiota, living in close symbiosis since birth and even before. The huge impact that the billons of microscopic cells living in our gut have on our gastrointestinal and systemic health cannot be overestimated. The enormous progress that has been made in the past decade in our still very incomplete understanding of the gut microbiota is opening the door to potential applications in human health that were simply unthinkable before. One of the most interesting aspects of this new scientific horizon is the fact that we may identify (or even create in the laboratory) and utilize many of these "friendly bacteria" to protect, or improve our health. Thus, strains of probiotic microorganisms are being identified and studied in a vast array of clinical scenarios. Among the most investigated areas for probiotics is the gastrointestinal health of children. The topics addressed in this book are spanning from the development of the gut microbiota in the fetus and newborn all the way to current and potential applications in disparate conditions such as necrotizing enterocolitis, or infectious, or inflammatory conditions affecting the child. The book is written in a rigorous, evidence based manner by an international group of outstanding experts in these fields and is aimed at pediatric gastroenterologists, pediatricians and physician scientists alike.

ISBN: 9783030146368

Standard No.: 10.1007/978-3-030-14636-8doiSubjects--Topical Terms:

1360756
Pediatric gastroenterology.

LC Class. No.: RJ446 / .P76 2019

Dewey Class. No.: 618.9233

Probiotics and child gastrointestinal health = advances in microbiology, infectious diseases and public health.. Volume 10 /
LDR:03392nmm a2200337 a 4500 001 2191877
003 DE-He213
005 20190617135135.0
006 m d
007 cr nn 008maaau
008 200506s2019 gw s 0 eng d
020 $a 9783030146368 $q (electronic bk.)
020 $a 9783030146351 $q (paper)
024 7 $a 10.1007/978-3-030-14636-8 $2 doi
035 $a 978-3-030-14636-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RJ446 $b .P76 2019
072 7 $a MMFM $2 bicssc
072 7 $a MED052000 $2 bisacsh
072 7 $a MKFM $2 thema
082 0 4 $a 618.9233 $2 23
090 $a RJ446 $b .P962 2019
245 0 0 $a Probiotics and child gastrointestinal health $h [electronic resource] : $b advances in microbiology, infectious diseases and public health. $n Volume 10 / $c edited by Stefano Guandalini, Flavia Indrio.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a viii, 150 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology ; $v v.1125
505 0 $a From the contents: 1. The newborn -- Microbiota development of newborns starts in utero -- Pathogenesis and possible prevention of Necrotizing Enterocolitis -- Can post-biotics represent a new strategy for NEC? - 2. The Infant -- Preventing and treating colics -- Food Allergy prevention -- Can celiac disease be prevented with probiotics? 3. The child -- Fighting fatty liver with probiotics -- Inflammatory Bowel Disease -- Acute Infectious Diarrhea -- Functional GI disorders -- Clostridium difficile colitis prevention and treatment.
520 $a This book shows the huge impact the gut microbiota has on the gastrointestinal health of humans with a particular focus on children. It also highlights the potential use of probiotic microorganisms to protect or improve children's gastrointestinal health. Humans are not single organisms: We are a multi-organism structure composed of ourselves and our microbiota, living in close symbiosis since birth and even before. The huge impact that the billons of microscopic cells living in our gut have on our gastrointestinal and systemic health cannot be overestimated. The enormous progress that has been made in the past decade in our still very incomplete understanding of the gut microbiota is opening the door to potential applications in human health that were simply unthinkable before. One of the most interesting aspects of this new scientific horizon is the fact that we may identify (or even create in the laboratory) and utilize many of these "friendly bacteria" to protect, or improve our health. Thus, strains of probiotic microorganisms are being identified and studied in a vast array of clinical scenarios. Among the most investigated areas for probiotics is the gastrointestinal health of children. The topics addressed in this book are spanning from the development of the gut microbiota in the fetus and newborn all the way to current and potential applications in disparate conditions such as necrotizing enterocolitis, or infectious, or inflammatory conditions affecting the child. The book is written in a rigorous, evidence based manner by an international group of outstanding experts in these fields and is aimed at pediatric gastroenterologists, pediatricians and physician scientists alike.
650 0 $a Pediatric gastroenterology. $3 1360756
650 0 $a Probiotics. $3 1532006
650 0 $a Gastrointestinal system $x Microbiology. $3 665488
650 1 4 $a Medical Microbiology. $3 890951
650 2 4 $a Infectious Diseases. $3 894100
650 2 4 $a Microbiology. $3 536250
650 2 4 $a Gastroenterology. $3 828956
700 1 $a Guandalini, Stefano. $3 1530964
700 1 $a Indrio, Flavia. $3 3411648
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v v.1125. $3 3411649
856 4 0 $u https://doi.org/10.1007/978-3-030-14636-8
950 $a Biomedical and Life Sciences (Springer-11642)